| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Artery Obstruction | 19 | 2015 | 41 | 2.550 |
Why?
|
| Vascular Surgical Procedures | 12 | 2019 | 90 | 2.270 |
Why?
|
| Lower Extremity | 7 | 2019 | 100 | 1.940 |
Why?
|
| Ischemia | 8 | 2014 | 98 | 1.600 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2014 | 70 | 1.390 |
Why?
|
| Stents | 9 | 2016 | 178 | 1.310 |
Why?
|
| Hypertension, Renovascular | 8 | 2009 | 15 | 1.140 |
Why?
|
| Renal Artery | 14 | 2015 | 47 | 1.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 6 | 2014 | 49 | 1.110 |
Why?
|
| Atherosclerosis | 8 | 2015 | 767 | 0.980 |
Why?
|
| Postoperative Complications | 12 | 2020 | 779 | 0.970 |
Why?
|
| Angioplasty, Balloon | 6 | 2016 | 35 | 0.920 |
Why?
|
| Kidney | 11 | 2009 | 515 | 0.920 |
Why?
|
| Vascular Diseases | 4 | 2020 | 65 | 0.900 |
Why?
|
| Aged | 50 | 2020 | 10288 | 0.870 |
Why?
|
| Treatment Outcome | 28 | 2019 | 3294 | 0.870 |
Why?
|
| Angioplasty | 5 | 2014 | 34 | 0.860 |
Why?
|
| Anesthesia, General | 2 | 2012 | 28 | 0.800 |
Why?
|
| Anesthesia, Conduction | 2 | 2012 | 25 | 0.800 |
Why?
|
| Amputation | 3 | 2018 | 38 | 0.790 |
Why?
|
| Quality Indicators, Health Care | 2 | 2019 | 59 | 0.760 |
Why?
|
| Venous Thrombosis | 4 | 2012 | 49 | 0.750 |
Why?
|
| Male | 61 | 2020 | 19091 | 0.740 |
Why?
|
| Female | 57 | 2020 | 19859 | 0.700 |
Why?
|
| Time Factors | 22 | 2019 | 2146 | 0.660 |
Why?
|
| Humans | 66 | 2020 | 31836 | 0.650 |
Why?
|
| Middle Aged | 36 | 2019 | 11824 | 0.620 |
Why?
|
| Aged, 80 and over | 22 | 2017 | 3988 | 0.620 |
Why?
|
| Ultrasonography, Doppler, Duplex | 13 | 2016 | 46 | 0.610 |
Why?
|
| Aortic Aneurysm | 3 | 2011 | 11 | 0.560 |
Why?
|
| Risk Assessment | 13 | 2014 | 1431 | 0.540 |
Why?
|
| Risk Factors | 25 | 2020 | 3851 | 0.540 |
Why?
|
| Mesenteric Vascular Occlusion | 4 | 2016 | 12 | 0.490 |
Why?
|
| Embolectomy | 1 | 2014 | 5 | 0.480 |
Why?
|
| Hypertension, Renal | 1 | 2014 | 29 | 0.470 |
Why?
|
| Vena Cava Filters | 3 | 2010 | 13 | 0.470 |
Why?
|
| Thromboembolism | 1 | 2014 | 34 | 0.470 |
Why?
|
| Retrospective Studies | 24 | 2020 | 3488 | 0.470 |
Why?
|
| Aortography | 1 | 2014 | 16 | 0.470 |
Why?
|
| Follow-Up Studies | 14 | 2020 | 2271 | 0.460 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 38 | 0.460 |
Why?
|
| Kidney Diseases | 6 | 2011 | 249 | 0.450 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2014 | 83 | 0.440 |
Why?
|
| Software | 1 | 2014 | 127 | 0.440 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 912 | 0.440 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 180 | 0.440 |
Why?
|
| Multivariate Analysis | 9 | 2017 | 686 | 0.440 |
Why?
|
| Registries | 9 | 2017 | 295 | 0.440 |
Why?
|
| Prospective Studies | 15 | 2020 | 2277 | 0.430 |
Why?
|
| Clinical Competence | 1 | 2015 | 325 | 0.410 |
Why?
|
| Length of Stay | 6 | 2014 | 315 | 0.410 |
Why?
|
| Comorbidity | 8 | 2017 | 566 | 0.400 |
Why?
|
| Logistic Models | 7 | 2017 | 777 | 0.400 |
Why?
|
| Anesthesia, Local | 1 | 2011 | 16 | 0.390 |
Why?
|
| Career Choice | 2 | 2015 | 41 | 0.390 |
Why?
|
| Retinal Vessels | 2 | 2015 | 19 | 0.380 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 42 | 0.380 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2017 | 34 | 0.380 |
Why?
|
| Patient Selection | 5 | 2014 | 276 | 0.380 |
Why?
|
| Vena Cava, Inferior | 2 | 2010 | 32 | 0.380 |
Why?
|
| Severity of Illness Index | 10 | 2014 | 899 | 0.360 |
Why?
|
| Embolism, Cholesterol | 2 | 2007 | 6 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1424 | 0.350 |
Why?
|
| Cardiovascular Diseases | 6 | 2015 | 1122 | 0.350 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 22 | 0.340 |
Why?
|
| Societies, Medical | 3 | 2019 | 161 | 0.340 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2010 | 87 | 0.340 |
Why?
|
| Vascular Patency | 7 | 2017 | 69 | 0.330 |
Why?
|
| North Carolina | 10 | 2017 | 1514 | 0.330 |
Why?
|
| Linear Models | 5 | 2017 | 449 | 0.320 |
Why?
|
| Hand Strength | 2 | 2020 | 100 | 0.320 |
Why?
|
| Students, Medical | 1 | 2010 | 129 | 0.320 |
Why?
|
| Device Removal | 2 | 2010 | 33 | 0.310 |
Why?
|
| Arteriosclerosis | 4 | 2005 | 122 | 0.310 |
Why?
|
| Creatinine | 9 | 2009 | 195 | 0.300 |
Why?
|
| Predictive Value of Tests | 10 | 2017 | 874 | 0.300 |
Why?
|
| Reoperation | 4 | 2014 | 226 | 0.300 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 40 | 0.290 |
Why?
|
| Glomerular Filtration Rate | 9 | 2008 | 305 | 0.290 |
Why?
|
| Saphenous Vein | 2 | 2017 | 20 | 0.290 |
Why?
|
| Popliteal Vein | 1 | 2006 | 3 | 0.290 |
Why?
|
| Femoral Vein | 1 | 2006 | 9 | 0.280 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2006 | 6 | 0.280 |
Why?
|
| Iliac Vein | 1 | 2006 | 8 | 0.280 |
Why?
|
| Chi-Square Distribution | 5 | 2017 | 298 | 0.280 |
Why?
|
| Prosthesis Design | 5 | 2014 | 95 | 0.280 |
Why?
|
| Patient Discharge | 2 | 2020 | 183 | 0.270 |
Why?
|
| Balloon Occlusion | 1 | 2006 | 36 | 0.270 |
Why?
|
| Thrombectomy | 1 | 2006 | 73 | 0.270 |
Why?
|
| Odds Ratio | 5 | 2017 | 470 | 0.260 |
Why?
|
| Anticoagulants | 1 | 2006 | 122 | 0.260 |
Why?
|
| Capillaries | 1 | 2005 | 24 | 0.260 |
Why?
|
| Retinal Diseases | 1 | 2005 | 20 | 0.250 |
Why?
|
| Patient Care Team | 2 | 2019 | 129 | 0.250 |
Why?
|
| Hospital Mortality | 3 | 2014 | 190 | 0.240 |
Why?
|
| Cohort Studies | 11 | 2012 | 1824 | 0.240 |
Why?
|
| Blood Pressure | 10 | 2011 | 843 | 0.240 |
Why?
|
| Aneurysm | 3 | 2014 | 21 | 0.240 |
Why?
|
| Disease Progression | 7 | 2019 | 593 | 0.230 |
Why?
|
| Thrombolytic Therapy | 2 | 2014 | 63 | 0.230 |
Why?
|
| Adult | 16 | 2017 | 9327 | 0.220 |
Why?
|
| Coronary Disease | 1 | 2005 | 213 | 0.220 |
Why?
|
| Embolism | 1 | 2003 | 6 | 0.220 |
Why?
|
| Carotid Stenosis | 2 | 2013 | 58 | 0.220 |
Why?
|
| Renal Dialysis | 4 | 2011 | 279 | 0.220 |
Why?
|
| Renal Circulation | 3 | 2014 | 13 | 0.220 |
Why?
|
| Incidence | 8 | 2015 | 1192 | 0.210 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 43 | 0.210 |
Why?
|
| Thrombosis | 1 | 2003 | 72 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 504 | 0.210 |
Why?
|
| Aortic Valve | 1 | 2002 | 47 | 0.210 |
Why?
|
| Mitral Valve | 1 | 2002 | 33 | 0.210 |
Why?
|
| Corneal Transplantation | 1 | 2002 | 14 | 0.200 |
Why?
|
| Corneal Diseases | 1 | 2002 | 10 | 0.200 |
Why?
|
| Heart Valve Prosthesis | 1 | 2002 | 54 | 0.200 |
Why?
|
| Databases as Topic | 2 | 2011 | 22 | 0.200 |
Why?
|
| North America | 2 | 2011 | 32 | 0.200 |
Why?
|
| Keratoconus | 1 | 2019 | 2 | 0.170 |
Why?
|
| Cross-Linking Reagents | 1 | 2019 | 16 | 0.170 |
Why?
|
| After-Hours Care | 1 | 2019 | 6 | 0.170 |
Why?
|
| Mesenteric Artery, Superior | 3 | 2016 | 9 | 0.170 |
Why?
|
| Benchmarking | 1 | 2019 | 22 | 0.170 |
Why?
|
| Collagen | 2 | 2019 | 225 | 0.170 |
Why?
|
| Hospital Costs | 1 | 2019 | 37 | 0.170 |
Why?
|
| Operating Rooms | 1 | 2019 | 33 | 0.170 |
Why?
|
| Survival Rate | 7 | 2020 | 884 | 0.170 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2013 | 63 | 0.160 |
Why?
|
| Population Surveillance | 2 | 2012 | 125 | 0.160 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 240 | 0.160 |
Why?
|
| Celiac Artery | 2 | 2016 | 6 | 0.160 |
Why?
|
| United States | 8 | 2020 | 3925 | 0.150 |
Why?
|
| Recurrence | 4 | 2016 | 262 | 0.150 |
Why?
|
| Pulmonary Embolism | 2 | 2010 | 49 | 0.150 |
Why?
|
| Longitudinal Studies | 5 | 2014 | 771 | 0.150 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 143 | 0.150 |
Why?
|
| Psoas Muscles | 1 | 2017 | 19 | 0.150 |
Why?
|
| Prevalence | 6 | 2017 | 979 | 0.150 |
Why?
|
| Sex Distribution | 4 | 2009 | 195 | 0.150 |
Why?
|
| Marital Status | 1 | 2017 | 23 | 0.150 |
Why?
|
| Vertebral Artery | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cause of Death | 4 | 2020 | 238 | 0.140 |
Why?
|
| Sarcopenia | 1 | 2017 | 62 | 0.140 |
Why?
|
| Prognosis | 5 | 2020 | 1498 | 0.140 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 319 | 0.140 |
Why?
|
| Mesenteric Arteries | 3 | 2006 | 20 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 34 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2017 | 115 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2018 | 491 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 27 | 0.130 |
Why?
|
| Age Distribution | 3 | 2009 | 206 | 0.130 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2015 | 3 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2016 | 122 | 0.130 |
Why?
|
| Microvessels | 1 | 2015 | 25 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 52 | 0.130 |
Why?
|
| Hypertension | 4 | 2014 | 956 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2017 | 24 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 124 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2015 | 66 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 764 | 0.120 |
Why?
|
| Limb Salvage | 1 | 2014 | 22 | 0.120 |
Why?
|
| Furosemide | 1 | 2014 | 8 | 0.120 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2014 | 11 | 0.120 |
Why?
|
| Proportional Hazards Models | 5 | 2019 | 756 | 0.120 |
Why?
|
| Observer Variation | 1 | 2014 | 105 | 0.110 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 30 | 0.110 |
Why?
|
| Fingers | 1 | 2014 | 64 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 53 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 94 | 0.110 |
Why?
|
| Diastole | 2 | 2011 | 96 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 45 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 132 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 51 | 0.110 |
Why?
|
| Oxygen | 1 | 2014 | 140 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 156 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 72 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2015 | 306 | 0.100 |
Why?
|
| Critical Illness | 1 | 2012 | 87 | 0.100 |
Why?
|
| Kidney Function Tests | 3 | 2009 | 106 | 0.100 |
Why?
|
| Ultrasonography | 4 | 2009 | 378 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 215 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2011 | 47 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 28 | 0.100 |
Why?
|
| Duodenum | 1 | 2010 | 19 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 1323 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 98 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 85 | 0.090 |
Why?
|
| Aneurysm, False | 1 | 2010 | 14 | 0.090 |
Why?
|
| Comprehension | 1 | 2010 | 19 | 0.090 |
Why?
|
| Child | 3 | 2019 | 2425 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 384 | 0.090 |
Why?
|
| Program Development | 1 | 2010 | 96 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2011 | 349 | 0.090 |
Why?
|
| Sepsis | 1 | 2011 | 158 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2010 | 184 | 0.090 |
Why?
|
| Radiography | 4 | 2015 | 376 | 0.090 |
Why?
|
| Cognition | 1 | 2013 | 551 | 0.080 |
Why?
|
| Antihypertensive Agents | 3 | 2009 | 351 | 0.080 |
Why?
|
| Morbidity | 3 | 2007 | 99 | 0.080 |
Why?
|
| Geriatric Assessment | 2 | 2017 | 390 | 0.080 |
Why?
|
| Probability | 2 | 2009 | 158 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2008 | 31 | 0.080 |
Why?
|
| Renal Insufficiency | 2 | 2008 | 58 | 0.080 |
Why?
|
| Curriculum | 1 | 2010 | 208 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 169 | 0.080 |
Why?
|
| Aorta, Abdominal | 1 | 2008 | 28 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 120 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2010 | 895 | 0.080 |
Why?
|
| Filtration | 1 | 2007 | 3 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2007 | 17 | 0.070 |
Why?
|
| Particle Size | 1 | 2007 | 46 | 0.070 |
Why?
|
| Perfusion | 1 | 2007 | 73 | 0.070 |
Why?
|
| Phlebography | 1 | 2007 | 26 | 0.070 |
Why?
|
| Medical Records | 1 | 2007 | 76 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 172 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 353 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 76 | 0.070 |
Why?
|
| Ethnic Groups | 2 | 2015 | 476 | 0.070 |
Why?
|
| Age Factors | 4 | 2020 | 1187 | 0.070 |
Why?
|
| Adolescent | 3 | 2004 | 3511 | 0.070 |
Why?
|
| Proteinuria | 1 | 2005 | 59 | 0.060 |
Why?
|
| Photography | 1 | 2005 | 42 | 0.060 |
Why?
|
| Heart Function Tests | 1 | 2005 | 9 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2005 | 23 | 0.060 |
Why?
|
| Sex Factors | 3 | 2016 | 662 | 0.060 |
Why?
|
| Retina | 1 | 2005 | 61 | 0.060 |
Why?
|
| Viscera | 1 | 2004 | 17 | 0.060 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2004 | 2 | 0.060 |
Why?
|
| European Continental Ancestry Group | 2 | 2005 | 1169 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2005 | 461 | 0.060 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2004 | 50 | 0.060 |
Why?
|
| Peritonitis | 1 | 2003 | 14 | 0.050 |
Why?
|
| New Zealand | 1 | 2002 | 9 | 0.050 |
Why?
|
| Aging | 2 | 2005 | 941 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 409 | 0.050 |
Why?
|
| African Americans | 2 | 2005 | 1428 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2016 | 400 | 0.040 |
Why?
|
| Corneal Topography | 1 | 2019 | 1 | 0.040 |
Why?
|
| Refraction, Ocular | 1 | 2019 | 2 | 0.040 |
Why?
|
| Riboflavin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2002 | 665 | 0.040 |
Why?
|
| Models, Economic | 1 | 2019 | 20 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2010 | 148 | 0.040 |
Why?
|
| Hyperplasia | 2 | 2013 | 38 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2019 | 23 | 0.040 |
Why?
|
| Specialization | 1 | 2019 | 31 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 34 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 103 | 0.040 |
Why?
|
| Ultraviolet Therapy | 1 | 2019 | 40 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2019 | 73 | 0.040 |
Why?
|
| Carotid Arteries | 2 | 2013 | 98 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 185 | 0.040 |
Why?
|
| Infant | 1 | 2002 | 1055 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 1527 | 0.040 |
Why?
|
| Angiography | 2 | 2009 | 80 | 0.040 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2017 | 11 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 33 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2002 | 1259 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2019 | 159 | 0.040 |
Why?
|
| Blood Flow Velocity | 2 | 2008 | 76 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2017 | 68 | 0.040 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 7 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 833 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 766 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 45 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 41 | 0.030 |
Why?
|
| Nephrectomy | 2 | 2010 | 123 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 56 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 397 | 0.030 |
Why?
|
| Perception | 1 | 2015 | 98 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 318 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 53 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 28 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2014 | 181 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 42 | 0.030 |
Why?
|
| Acute Disease | 1 | 2014 | 252 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 272 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2013 | 108 | 0.030 |
Why?
|
| Mice | 2 | 2013 | 2476 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 92 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2013 | 152 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 128 | 0.030 |
Why?
|
| Cell Movement | 1 | 2013 | 170 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 370 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2004 | 487 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2013 | 444 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 994 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 738 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 564 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2015 | 632 | 0.020 |
Why?
|
| Mass Screening | 1 | 2012 | 263 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2009 | 48 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 2010 | 56 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 687 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1012 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2010 | 186 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 71 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 64 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 1586 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2009 | 134 | 0.020 |
Why?
|
| Intermittent Claudication | 1 | 2008 | 11 | 0.020 |
Why?
|
| Animals | 2 | 2013 | 7450 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 463 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 341 | 0.020 |
Why?
|
| Endarterectomy | 1 | 2005 | 6 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2005 | 43 | 0.020 |
Why?
|
| Nephrosclerosis | 1 | 1995 | 4 | 0.020 |
Why?
|
| Systole | 1 | 2005 | 99 | 0.020 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2004 | 2 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2004 | 7 | 0.010 |
Why?
|
| Gels | 1 | 2004 | 31 | 0.010 |
Why?
|
| Tunica Intima | 1 | 2004 | 57 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 73 | 0.010 |
Why?
|
| Brachial Artery | 1 | 2004 | 69 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 125 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 164 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 629 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 56 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 218 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 465 | 0.010 |
Why?
|